1 3 9 9 a r t I C l e S In the mammalian brain, neurogenesis persists throughout adulthood in the subgranular zone (SGZ) of the hippocampal dentate gyrus 1 and the subventricular zone (SVZ) of the lateral ventricles 2 . In these niches, neural stem cell (NSC) maintenance, proliferation, and differentiation are orchestrated by a delicate balance of microenvironmental cues. The importance of such instructive signals in the niche is supported by the absence of significant neurogenesis in the adult mammalian CNS outside of these regions 3, 4 and by the development of aberrant neurogenesis in patients with pathologies that disrupt the natural chemistry of the brain, for example epilepsy 5 , inflammation 6 , and neurodegenerative diseases 7 .
In the mammalian brain, neurogenesis persists throughout adulthood in the subgranular zone (SGZ) of the hippocampal dentate gyrus 1 and the subventricular zone (SVZ) of the lateral ventricles 2 . In these niches, neural stem cell (NSC) maintenance, proliferation, and differentiation are orchestrated by a delicate balance of microenvironmental cues. The importance of such instructive signals in the niche is supported by the absence of significant neurogenesis in the adult mammalian CNS outside of these regions 3, 4 and by the development of aberrant neurogenesis in patients with pathologies that disrupt the natural chemistry of the brain, for example epilepsy 5 , inflammation 6 , and neurodegenerative diseases 7 .
In the SGZ, adult neurogenesis entails the activation of quiescent type 1 NSCs to produce mitotic, multipotent type 2a NSCs 8, 9 ; the differentiation of the type 2a NSCs to lineage-committed, proliferative type 2b neuronal precursors and subsequently type 3 neuroblasts; and the survival, migration, and maturation of neuroblasts as they differentiate into granule cells that synaptically integrate into the existing neural network [8] [9] [10] . Each of these stages is regulated by signals within the niche. For example, bone morphogenic protein 11 and Notch 12, 13 signaling modulate the balance between quiescent and proliferative NSCs, and Sonic hedgehog 14 , fibroblast growth factor-2 (ref. 15) , vascular endothelial growth factor 16 and Wnt7a 17 regulate NSC proliferation.
Although there is increasing knowledge of niche factors that regulate NSC division, substantially less is known about key signals that instruct cells in the SGZ to undergo neuronal differentiation 18, 19 . GABA inputs from local neuronal circuitry 20 and systemic retinoic acid levels 21 modulate NSC neuronal fate commitment. Furthermore, while neuronal differentiation precedes gliogenesis during CNS development, adult hippocampal astrocytes directly induce neuronal differentiation of NSCs in vitro via both secreted and membraneassociated factors 22 , and the former have since been found to include Wnt3a 23 and potentially additional secreted signals 19 . However, the membrane-bound astrocytic components 22 that may be critical for neuronal fate commitment in vivo remain unknown.
Ephrins are a diverse class of glycophosphatidylinositol-linked (ephrinA1-6) and transmembrane (ephrinB1-3) cell surface ligands that bind Eph receptors (EphA1-10 and EphB1-6) on opposing cell membranes to initiate bidirectional signaling 24 . Ephrin-Eph signaling is traditionally known to control the spatial organization of cells and their projections by modulating intercellular attractive and repulsive forces 25 . For example, ephrin-Eph signaling instructs topographical mapping of hippocampo-septal and entorhino-hippocampal projections during development 26 and regulates neuronal dendrite spine morphogenesis and synaptogenesis of adult hippocampal neurons 27 .
Recent studies have also indicated that ephrin-Eph signaling has an earlier role in regulating stem cell behavior. For example, ephrin-AEphA signaling promotes embryonic telencephalic NSC differentiation 28 , and ephrin-B3-EphB3 signaling may exert an anti-proliferative effect on NSCs in the developing SVZ 29 . In the adult CNS, infusion of ephrin-B2 or EphB2 ectodomains into the lateral ventricles induced SVZ NSC proliferation and disrupted neuroblast migration through the rostral migratory stream 30 . In addition, signaling between ephrin-A2 + neural stem cells, and EphA7 + ependymal cells and putative stem cells, 1 4 0 0 VOLUME 15 | NUMBER 10 | OCTOBER 2012 nature neurOSCIenCe a r t I C l e S was shown to suppress proliferation of NSCs in the adult SVZ 31 . In the adult SGZ, ephrin-B3 + neurons in the granule cell layer have been proposed to regulate EphB1 + NSC polarity, SGZ positioning, and proliferation 32 . Similarly, in Efna5 −/− mice, a decrease in both the proliferation of NSCs and the survival and maturation of newborn neurons in the adult SGZ was observed 33 . Thus, ephrin-Eph signaling has been shown to affect the proliferation, migration and survival of adult NSCs; however, its potential regulation of NSC fate commitment remains unknown.
We found that ephrin-B2 presented by hippocampal astrocytes instructed neuronal differentiation of NSCs in the SGZ of the adult hippocampus. Furthermore, ephrin-B2-EphB4 forward signaling induced neuronal differentiation of NSCs by activating β-catenin, independent of Wnt signaling, and inducing transcription of proneural transcription factors. Our findings describe a juxtacrine signaling mechanism by which astrocytes actively regulate neuronal differentiation of NSCs during adult neurogenesis.
RESULTS

Ephrin-B2 and EphB4 expression in the SGZ
In the SGZ, type 1 NSCs express the SRY-box 2 (Sox2) transcription factor and stain for glial fibrilary acid protein (GFAP) and Nestin along radial granule cell layer (GCL)-spanning or horizontal processes 13 . Type 2a NSCs 9 remain Sox2 + and Nestin + , but downregulate GFAP expression, and fate-restricted, proliferative type 2b neuronal precursors coexpress Sox2 and doublecortin (DCX) while downregulating Nestin expression. The latter then mature into (Sox2 − DCX + ) type 3 neuroblasts, which migrate into the GCL and become neuronal-specific nuclear protein (NeuN) + DCX − granule neurons 8, 10, 11, 13 . Alternatively, type 1 NSCs can differentiate into stellate, Sox2 − GFAP + hippocampal astrocytes, which are primarily located in the hilus adjacent to the SGZ 10 .
As part of a candidate screen, we investigated ephrin-B2 expression in the hippocampal dentate gyrus. Antibody to Ephrin-B2 consistently labeled GFAP + astrocytes in the hilus, SGZ and molecular layer (Fig. 1a,b) . In contrast, EphB4, an ephrin-B2 receptor, was expressed by Sox2 + DCX − , Sox2 + DCX + , Sox2 − DCX + and Sox2 + GFAP − cells in the SGZ, as well as by the majority of cells in the GCL (Fig. 1a,c,d) . Thus, EphB4 appeared to be expressed in type 2a (Sox2 + DCX − GFAP − ) NSCs and persisted as these cells became type 2b neuronal precursors (Sox2 + DCX + ), type 3 neuroblasts (Sox2 − DCX + ) and eventually granule neurons. Some type 1 NSCs were EphB4 + , although EphB4 was not expressed at levels detectable by immunostaining in many cells (data not shown). Overall, these results indicate that astrocytes are a source of ephrin-B2 ligand in the dentate gyrus and suggest that EphB4-expressing NSCs, neuronal precursors and neuroblasts contact these ligand-expressing astrocytes (Fig. 1e,f) .
Ephrin-B2 increases neurogenesis in vitro and in vivo
Ephrin-Eph signaling begins with clustering of multiple ligand-receptor complexes at sites of cell-cell contact 24 . Thus, to initially explore a possible role for ephrin-B2 in regulating NSC fate, we added antibodyclustered ephrin-B2-Fc fusion molecules (Fc-ephrin-B2) 34 to adult hippocampus-derived NSCs in culture and found that they induced a strong, dose-dependent increase in NSC neuronal differentiation (Fig. 2a,b) . No biological activity was observed with monomeric, unclustered ephrin-B2 and Fc, consistent with previous findings 30, 34 , and no proliferative effect was observed under any conditions (data not shown). To investigate which receptor mediated Fc-ephrin-B2's activity, we pre-incubated the NSCs with an antibody to either EphB2 or EphB4, two known ephrin-B2 receptors, before adding Fc-ephrin-B2. Inhibition of EphB4, but not EphB2, significantly reduced Fc-ephrin-B2 induction of neuronal differentiation (P = 0.002; Fig. 2c ), indicating that EphB4 receptors mediate the proneuronal effect of Fc-ephrin-B2. Reverse transcription PCR (RT-PCR) and immunocytochemistry results confirmed that hippocampus-derived NSCs express EphB4 (Fig. 2d) npg a r t I C l e S in the SGZ through juxtacrine signaling, and therefore proceeded to investigate Fc-ephrin-B2 activity in vivo (Fig. 3) . Mitotic cells in the brain of adult rats were first labeled with BrdU, followed by bilateral hippocampal injections of phosphate-buffered saline (PBS), nonclustered ephrin-B2, antibody to Fc without ephrin-B2, or Fc-ephrin-B2 (Fig. 3a) . Histology revealed an increase in the number of BrdU + cells in the SGZ of rats injected with Fc-ephrin-B2 compared with rats treated with vehicle or clustering antibody controls 5 d after injection ( Fig. 3c) , mirroring one report in the SVZ 30 . In addition, no difference in the percentage of BrdU + cells that co-stained as nonradial GFAP + astrocytes was observed between experimental groups on day 5 ( Supplementary Fig. 1a,b) . However, there was a considerable increase in the proportion of BrdU + cells that co-stained for DCX in animals injected with Fc-ephrin-B2 (80.6 ± 0.87%) as compared with those injected with PBS (40.65 ± 4.15%), ephrin-B2 (50.3 ± 3.45%) or antibody to Fc (50.37 ± 9.28%) (Fig. 3b,d ). These results indicate that ephrin-B2 signaling in vivo may regulate early stages of adult hippocampal neurogenesis by modulating NSC proliferation and/or differentiation, but further analysis is required to distinguish between these two possibilities.
Astroctyic ephrin-B2 regulates neurogenesis in vitro Exogenous ephrin-B2 elevates hippocampal neurogenesis, and astrocytes expressing ephrin-B2 contact NSCs in the hippocampus; however, it remains unclear whether astrocytic ephrin-B2 regulates NSC fate. Previous studies have found that hippocampal astrocytes promote neuronal differentiation of co-cultured NSCs through secretion of soluble Wnt3a and by unidentified membrane-bound signaling molecules 22, 23 . To determine whether ephrin-B2 is an important component of this membrane-associated activity, we first verified its expression in cultured hippocampal astrocytes. Consistent with our in vivo results ( Fig. 1) , quantitative PCR (QPCR) revealed that hippocampus-derived astrocytes express Efnb2 mRNA at levels three orders of magnitude higher than cultured NSCs ( Supplementary  Fig. 2a) . Notably, cultured NSCs downregulated EphB4 and upregulated ephrin-B2 expression following astrocytic differentiation, yet maintained EphB4 expression on their soma following neuronal differentiation into DCX + immature neurons (Supplementary Fig. 2b ).
We then analyzed whether RNAi-mediated knockdown of ephrin-B2 in hippocampal astrocytes could compromise their ability to induce neuronal differentiation of NSCs in co-culture. We screened five candidate Efnb2 short hairpin RNA (shRNA) sequences expressed under a human and/or a mouse U6 promoter upstream of a UBC promoter-eGFP expression cassette (Supplementary Fig. 3 ). Following lentiviral delivery, QPCR analysis revealed that two shRNA constructs (Efnb2 shRNA #1 and #2) could knock down Efnb2 mRNA levels in astrocytes by approximately 90 and 85%, respectively (Fig. 4a) . Next, BrdU-labeled NSCs (>95%) were seeded on near-confluent layers of mitotically inactive astrocytes that were either naive or expressing Efnb2 shRNA #1 or #2, or lacZ shRNA, and the co-cultures were immunostained after 6 d. NSC proliferation was minimal in all experimental groups. However, the percentage of βIII-tubulin + BrdU + cells increased from 6.79 ± 0.62% in NSC-only control cultures to 14.2 ± 0.55% in NSC and naive astrocyte co-cultures (Fig. 4b) , levels that are consistent with a prior NSC-astrocyte co-culture study 22 , and the neuronally differentiated NSCs were primarily located in close proximity to astrocytes (Fig. 4c) . A similar proneuronal effect was maintained npg a r t I C l e S by astrocytes expressing the lacZ shRNA (15.4 ± 1.12%); however, knockdown of ephrin-B2 expression in Efnb2 shRNA #1 and #2 astrocytes decreased their neuronal instructive potential by ~70% (to 9.09 ± 0.39% and 9.51 ± 0.11% βIII-tubulin + BrdU + cells, respectively). Notably, this decrease in NSC neuronal differentiation resulting from ephrin-B2 knockdown is comparable to the previously observed ~55% loss when NSCs were cultured in astrocyte-conditioned medium rather than in co-culture 22 . Furthermore, antibody blockage of EphB4 receptors in the co-culture assay also inhibited the proneuronal effect of naive astrocytes, resulting in only 10.75 ± 0.87% of NSCs differentiating into βIII-tubulin + BrdU + neurons. Thus, ephrin-B2 is an important membrane-presented factor that hippocampal astrocytes employ to instruct neuronal differentiation of NSCs in vitro, and EphB4 receptors on NSCs transduce this signal.
Loss of astrocytic ephrin-B2 decreases neurogenesis in SGZ
To determine whether endogenous ephrin-B2 signaling promotes neuronal differentiation in vivo, we injected adult rats intrahippocampally with lentiviral vectors encoding Efnb2 shRNA #1 or #2, or control lacZ shRNA. After 2 weeks, mitotic cells in the SGZ were labeled with BrdU, and tissue samples were collected 5 d later (Fig. 5a) . In GFP + regions of the hippocampus, ephrin-B2 levels from rats treated with the Efnb2 shRNA constructs were markedly lower than in sections from PBS-or lacZ shRNA-treated rats, which exhibited ephrin-B2 expression in patterns similar to GFAP staining (Fig. 5b) . We noted that neurons, rather than astrocytes, expressed GFP in the lentiviral vector-infected hippocampi; however, it was later confirmed through administration of an otherwise identical lentiviral vector in which the UBC promoter was replaced with a Gfap promoter 22 that the low GFP expression initially observed in astrocytes was a result of the ubiquitin promoter ( Supplementary Fig. 4a,b) . In either case, the U6 promoter driving the shRNA expression mediated strong ephrin-B2 knockdown in hippocampal astrocytes ( Fig. 5b and Supplementary Fig. 4c ). Next, BrdU + and DCX + BrdU + cells in the SGZ were quantified in GFP + hippocampi (Fig. 5c) . In contrast with results obtained after administration of exogenous ephrin-B2, no significant difference (P = 0.217) in the number of BrdU + cells per mm 3 was observed in rats treated with Efnb2 shRNA #1 (33.2 ± 11.3%) and #2 (22.5 ± 2.50%) versus lacZ shRNA control rats (29.0 ± 7.20%; Fig. 5d ), indicating that endogenous ephrin-B2 signaling does not by itself regulate the proliferation of NSCs and type 2b neuronal precursors. However, consistent with the proneuronal effect of Fc-ephrin-B2 in vitro and in vivo, the percentage of BrdU + cells that co-stained for DCX was significantly lower (P < 0.001) in animals treated with Efnb2 shRNA #1 (32.3 ± 4.95%) and #2 (41.6 ± 3.41%) compared with lacZ shRNA (59.4 ± 2.33%; Fig. 5e ). Thus, knockdown of ephrin-B2 expression in hippocampal astrocytes decreased neurogenesis in the adult SGZ. Figure 4 Efnb2 RNAi decreases the proneuronal effect of hippocampusderived astrocytes in vitro. (a) Efnb2 shRNA lentiviral vectors (#1 and #2) inhibited Efnb2 expression in hippocampus-derived astrocytes. Expression levels were measured by QPCR and normalized to Efnb2 expression in non-infected hippocampus-derived astrocytes (that is, 100%). In addition, hippocampus-derived astrocytes expressed orders of magnitude more Efnb2 than NSCs (n = 3, technical replicates). (b) Naive astrocytes and astrocytes expressing a control lacZ shRNA promoted neuronal differentiation of NSCs compared to NSC-only cultures. However, knockdown of astrocyte Efnb2 expression, or antibody blockage of NSC EphB4 receptors, significantly diminished the proneuronal effect of hippocampus-derived astrocytes, as seen by the decrease in the percentage of βIII-tubulin + BrdU + NSCs to levels closer to those observed in NSC-only cultures (n = 4, experimental replicates). The solid black line indicates the level of βIII-tubulin + BrdU + cells at the start of the experiment. (c) Representative confocal image of NSCs labeled with BrdU (white) differentiated into βIII-tubulin + neurons after co-culture with lentiviral vector-expressing (that is, GFP + ) astrocytes. NSCs adjacent to astrocytes had a higher propensity for neuronal differentiation. Scale bar represents 100 µm. *P < 0.01. Error bars represent ± s.d. (Fig. 6a) . Quiescent and mitotic cells in the SGZ were labeled β-galactosidase + (β-gal) and BrdU + in a near clonal fashion on day 0 (43.6 ± 7.95% of β-gal + cells were also BrdU + , 3.89 ± 1.00% of BrdU + cells were also β-gal + ), and these cells expanded, differentiated and migrated into the GCL over the 14-d observation period (Fig. 6b-h) . At the population level, β-gal + hippocampal cells initially (day 0) consisted of type 1 and 2a Nestin + Sox2 + NSCs (90.7 ± 1.79%), and a large fraction of β-gal + cells were specifically type 1, radial, GFAP + Sox2 + NSCs (53.8 ± 5.49%; Fig. 6b-f) . By day 5, the total number of β-gal + cells had increased, but to the same extent in Fc-ephrin-B2 and Fc control antibody groups (Supplementary Fig. 5a ). At this time point, however, a larger fraction of the β-gal + cell population in mice injected with Fc-ephrin-B2 had shifted from type 1 and 2a NSCs to neuronal fate-committed type 2b DCX + Sox2 + precursors and even more so to type 3 DCX + NeuroD1 + neuroblasts, as compared with mice injected with Fc control antibody (Fig. 6d,e) . By day 14, the total number of β-gal + cells was again consistent between experimental groups, but the increase in neuronal-fated β-gal + cells in mice injected with Fc-ephrin-B2 versus Fc control antibody persisted as type 2b and type 3 cells matured into NeuN + GCL neurons (Fig. 6d-f and Supplementary Fig. 5a ).
To gain further insights into the early fate decisions that ephrin-B2 modulates 10 , we analyzed individual β-gal + cell clusters that were likely clonal. This quantification was conducted at day 5 in Nestin and Sox2 co-stained hippocampal sections (a total of 916 and 1,145 cell clusters were analyzed in n = 4 Fc control antibody-treated and 5 Fc-ephrin-B2-treated brains, respectively). Type 1 and type 2a cells were identified by Nestin + Sox2 + co-staining and distinguished by morphology, and β-gal + Nestin − Sox2 − cells were deemed astrocytes or other neuronal cells (presumably neuronal precursors, neuroblasts or mature neurons) by morphology and positioning relative to the GCL (Fig. 6i) . We observed that the vast majority of clonal β-gal + cell clusters contained three or fewer cells. Notably, the average number of cells per cluster was 1.55 ± 0.03 and 1.54 ± 0.04 cells in Fc control antibody and Fc-ephrin-B2 sections, respectively, again indicating that Fc-ephrin-B2 did not enhance proliferation of type 1 or type 2a cells, in contrast with the previously observed increase in BrdU + cells with Fc-ephrin-B2 (Fig. 3c) . Furthermore, the cell phenotype distribution of the β-gal + cell clusters mirrored the overall populationlevel results (Fig. 6b-f and Supplementary Fig. 5b) . Specifically, the clearest result was that Fc-ephrin-B2-induced a significant decrease .01 ± 1.91% versus 17.8 ± 1.93%) and type 2a NSCs (2a, 2.51 ± 2.34% versus 10.8 ± 3.22%) and increased single neuroblasts or neurons (N, 49.2 ± 4.57% versus 30.9 ± 2.28%). Furthermore, ephrin-B2 decreased the number of doublets containing a type 1 (1 + X, 5.95 ± 1.47% versus 11.8 ± 2.03%) or type 2a (2a + X, 7.37 ± 3.00% versus 16.5 ± 6.03%) cell and increased neuroblasts or neuron doublets (N + N,16.3 ± 1.82% versus 3.87 ± 1.65%). Cluster size (1.55 ± 0.03 versus 1.54 ± 0.04) and overall β-gal + cell numbers ( Supplementary Fig. 5 ) were indistinguishable in Fc-ephrin-B2 versus control mice. Thus, ephrin-B2 signaling increased neuronal differentiation without altering proliferation. **P < 0.05. Error bars represent ± s.d. Five sections (ten hemispheres) analyzed in n = 4 antibody to Fc-treated and 5 Fc-ephrin-B2-treated brains; dotted and dashed lines indicate SGZ-hilus and GCL-MCL boundaries, respectively. Scale bars represent 10 µm (b-f,h) and 100 µm (g). npg a r t I C l e S (P < 0.05) in the percentage of single type 1 and single type 2a cells and a corresponding increase in the number of single neuronal cells (Fig. 6i) . Likewise, there was a statistically significant decrease (P < 0.05) in the overall number of doublets containing a type 1 cell (1 + X) or a type 2a cell (2a + X), accompanied by an increase in the number of neuronal + neuronal doublets. These results are consistent with the interpretation that ephrin-B2 induced the conversion of type 1 and 2a cells toward more differentiated phenotypes, either with or without a cell division event. Finally, there was no change in the percentage of astrocyte-containing clonal β-gal + cell clusters, as anticipated because of the low levels of gliogenesis previously observed in this experimental procedure (Supplementary Fig. 1 ). In summary, these results indicate that ephrin-B2 signaling increases the commitment of type 1 and type 2a NSCs to a neuronal fate.
Wnt-independent induction of NSC neuronal differentiation
Activation of the canonical Wnt pathway elevates levels of β-catenin, followed by its nuclear translocation and association with Tcf/Lef transcription factors. Recently, this pathway was shown to regulate adult NSC differentiation by transcriptionally activating the proneural transcription factor NeuroD1 (refs. 23,37) . In zebrafish paraxial mesoderm, ephrin-Eph forward signaling recruits β-catenin to adherens junctions 38 , and EphB receptors are known transcriptional targets of β-catenin-Tcf signaling in stem cells in the mammalian gut 39 . However, to the best of our knowledge, ephrin-Eph signaling has not previously been shown to activate β-catenin signaling. Notably, we found that Fc-ephrin-B2 stimulation progressively increased the levels of intracellular active β-catenin in cultured NSCs over a 24-h period (Fig. 7a) , initially detectable at 4 h and rising to maximal levels by 24 h. To determine whether this increased active β-catenin was mediated by EphB4, we pre-incubated NSCs with antibody to EphB4 before adding Fc-ephrin-B2. As observed in previous experiments (Figs. 2c and 4b) , EphB4 blockage decreased NSC responses to ephrin-B2 signaling and correspondingly limited the intracellular accumulation of active β-catenin (Fig. 7b) .
In the canonical Wnt pathway, intracellular β-catenin levels are directly regulated by glycogen synthase kinase-3 beta (GSK3β), which phosphorylates β-catenin and thereby marks it for proteasomal degradation 40 . To determine whether elevated β-catenin activity is required for ephrin-B2's proneuronal effect, we generated NSCs expressing a constitutively active form of GSK3β (GSK3β S9A) 41 . Following stimulation with Fc-ephrin-B2, both naive NSCs and NSCs carrying a control empty retroviral vector exhibited increased levels of active β-catenin (Fig. 7c) , consistent with prior results (Fig. 7a) . However, GSK3β S9A NSCs were unable to accumulate β-catenin in response to ephrin-B2 signaling. Furthermore, unlike naive cells, GSK3β S9A NSCs resisted neuronal differentiation when stimulated with Fc-ephrin-B2 or co-cultured with ephrin-B2 expressing naive astrocytes, indicating that increased active β-catenin levels are required for ephrin-B2's proneuronal effect (Fig. 7d,e) .
These results raise the possibility that ephrin-B2's pro-neuronal effect could involve Wnt ligand-mediated activation of β-catenin. To determine whether ephrin-B2 signaling indirectly activates β-catenin via upregulation of soluble Wnts in vivo, we used lentiviruses encoding a Tcf-Luciferase (Tcf-Luc) construct that reports β-catenin activity 42 and either a dominant-negative Wnt-IRES-GFP 23 (dnWnt-IRES-GFP) or IRES-GFP (control) cassette. We first confirmed that lentiviral-mediated expression of the soluble dnWnt by cultured NSCs significantly decreased luciferase reporter expression following incubation of the cells with Wnt3a (P < 0.01; Supplementary Fig. 6 ). β-catenin reporter vector, as well as vector expressing dnWnt or GFP alone, were then co-administered in vivo. After 2 weeks, mitotic cells in the rat hippocampi were labeled with BrdU, and Fc-ephrin-B2 or PBS was administered by intrahippocampal injection. After 24 h, in animals injected with Tcf-Luc and IRES-GFP constructs, Fc-ephrin-B2 increased the number of Luc + BrdU + cells, which also co-stained for active β-catenin, indicating that ephrin-B2 stimulates β-catenin signaling in vivo (Fig. 7f,g ). Furthermore, administration of the dnWnt-IRES-GFP vector with the Tcf-Luc vector knocked down the number of Luc + BrdU + cells proportionally in the Fc-ephrin-B2-and npg a r t I C l e S PBS-injected groups, indicating that Wnt signaling is active in the hippocampus, but that ephrin-B2 still stimulates β-catenin signaling even when Wnt is inhibited. Consistent with these results, dnWnt reduced the number of newborn neurons in both the Fc-ephrin-B2-and PBS-injected animals by day 5, but the former still showed a significantly higher number of DCX + BrdU + cells than the latter (P < 0.05; Fig. 7g) . Thus, ephin-B2 signaling does not apparently activate β-catenin through a soluble Wnt intermediate, and it can increase adult neurogenesis in the absence of Wnt signaling.
Finally, in NSC cultures stimulated with Fc-ephrin-B2, we observed a significant increase in the transcription of both Mash1 (Ascl1, P < 0.001) and Neurod1 (P = 0.001), proneural transcription factors that are known to be involved in adult hippocampal neurogenesis 37, 43 ( Supplementary Fig. 7a,b) . This mRNA upregulation presumably occurred in the subset of cells that underwent neuronal differentiation. Thus, our collective results strongly indicate that hippocampal astrocytes instruct neuronal differentiation of EphB4 + NSCs through juxtacrine ephrin-B2-EphB4 forward signaling, which induces the expression of proneural transcription factors via a β-catenin-dependent and soluble Wnt-independent mechanism.
DISCUSSION
Stem cell niches present repertoires of signals that control cell maintenance, proliferation and differentiation. Recent studies have identified several factors that regulate cell maintenance and proliferation in the adult NSC niche; however, few cues have been found to induce differentiation. Furthermore, although numerous soluble cues have been found to regulate adult neurogenesis, cell-cell interactions in the niche have, in general, been less studied. We found that ephrin-B2 presented from hippocampal astrocytes activated β-catenin signaling in NSCs, upregulated the expression of key proneural transcription factors and instructed their neuronal differentiation (Supplementary Fig. 8 ).
Hippocampal astrocytes, but not astrocytes derived from nonneurogenic regions of the CNS, regulate neurogenesis 22 , and recent expression profiling analyzed the differential expression of factors that underlie this activity 19 . However, ephrin-B2 was not represented on the Affymetrix chip used for this important comparative gene expression study, and cues dependent on cell-cell contact between the stem cells and hippocampal astrocytes have not been explored. The importance of ephrins and their receptors in axon guidance, neural tissue patterning and synapse formation is well established 24 ; however, less is known about their role in regulating adult NSCs. Several studies have shown that ephrin-Eph signaling can affect NSC proliferation [31] [32] [33] 44 ; however, these studies did not address the potential for ephrins and Ephs to regulate stem cell differentiation in the brain. Our results therefore represent, to the best of our knowledge, the first case of ephrin-Eph family regulation of NSC neuronal lineage commitment in the adult CNS.
We found that endogenous ephrin-B2 was expressed by astrocytes in close proximity to adult NSCs, shRNA-mediated knockdown of the endogenous ephrin-B2 substantially lowered the fraction of newborn cells that become DCX + neuronal precursors, and exogenous addition of ephrin-B2 induced the conversion of type 1 and 2a NSCs toward type 2b precursors and, subsequently, neurons (Figs. 2, 5 and 6) . Furthermore, lineage tracing analysis revealed a decrease in single type 1 and type 2a cells and an increase in the number of single neuroblasts and neurons in the presence of ephrin-B2, as well as a decrease in the number of cell doublets containing a type 1 or 2a cell with a corresponding increase in the number of neuroblast and neuron doublets (Fig. 6) . These results are consistent with ectopic ephrin-B2 inducing β-catenin signaling and upregulation of proneural transcription factors (Fig. 7 and Supplementary Fig. 7a,b) to induce NSC differentiation independent of cell division. Collectively, our results indicate that juxtacrine signaling between astrocytes and NSCs provides a mechanism for the niche to locally control NSC differentiation. Prior results have investigated the importance of Notch and EphB2 signaling in modulating the properties of neighboring cells in the NSC niche 45 and the importance of Notch in maintaining type 1 NSCs 13, 46 . Together, these results increasingly establish cell contact-dependent signaling as a critical mechanism for locally regulating multiple stages in adult neurogenesis.
Ephrin-Eph signaling is generally known to be bidirectional, such that the Eph-presenting cell can activate signaling in the ephrin ligand-expressing cell 24 . We found that adult NSCs upregulated ephrin-B2 and downregulated EphB4 expression following differentiation into astrocytes in vitro, yet retained EphB4 expression following neuronal differentiation (Supplementary Fig. 2b) . Ephrin-Eph signal feedback from the differentiating NSCs to neighboring cells could therefore represent a mechanism for dynamically remodeling the signaling environment of the niche, analogous to GDF11-dependent negative feedback from neurons to neural progenitors in the olfactory epithelium 47 or EGF-dependent feedback from neural progenitors to neural stem cells in the SVZ 48 . In addition, ephrin and Eph expression dynamics could help to control cell differentiation following NSC symmetric or asymmetric division 8 and thereby contribute to maintaining or modulating the cellular composition of the niche. The potential of ephrin signaling in general to support self-renewing, asymmetric cell division, that is, to generate a stem cell and a differentiated progeny, is virtually unexplored. There has been only one report of ephrin-mediated regulation of asymmetric stem cell division, in the ascidian embryo 49 .
Type 1 NSCs were depleted following ephrin-B2 administration (Fig. 6) , indicating that they may be direct targets of this ligand's signaling. However, although some type 1 cells expressed levels of EphB4 detectable by immunostaining and upregulated β-catenin signaling following ephrin-B2 addition, nearly all of the type 2a cells did so, and additional work will be needed to determine whether the observed differentiation of type 1 cells in response to ephrin-B2 is direct and/or indirect. In addition, although ephrin-B2 knockdown did not affect cell proliferation (Fig. 5d) and ephrin-B2 protein administration did not affect the proliferation of genetically labeled, Nestin-expressing stem and progenitor cells ( Fig. 6 and Supplementary Fig. 5 ), ephrin-B2 addition did result in the expansion of cells pre-labeled with BrdU in the rat brain. It is conceivable that, in addition to its clear role in inducing the differentiation of NSCs at the expense of stem cell maintenance or self-renewing cell divisions (Fig. 6) , ephrin-B2 could also modulate the expansion of later stage neuroblasts that are strongly labeled with BrdU, a possibility that could be explored in the future.
In summary, our findings suggest that ephrin-B2, a transmembrane factor known for its role in cell and tissue patterning, is an important regulator of adult hippocampal neurogenesis, the first known function of an Eph family protein in regulating neuronal lineage commitment of NSCs in the adult CNS. In addition, hippocampal astrocytes are the source of the ephrin-B2 signal, which further supports the emerging view that astroglia are active and essential regulators of an increasing number of adult CNS functions, including remodeling the neurogenic niche through local cellular interactions. Moreover, the discovery that ephrin-B2 signals through β-catenin adds further understanding to the interconnected and likely synergistic nature by which niche factors regulate adult neurogenesis. Finally, our findings may have future applications in modulating NSC function for treating brain injury and neurodegenerative disease. npg a r t I C l e S METhODS Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
ONLINE METhODS cell culture. NSCs isolated from the hippocampi of 6-week-old female Fisher 344 rats (Charles River) were cultured as previously described 14 on polyornithine/laminin-coated plates in DMEM/F12 medium (Life Technologies) containing N2 supplement (Life Technologies) and 20 ng ml −1 FGF-2 (PeproTech), with subculturing on reaching 80% confluency using Accutase (Phoenix Flow Systems). To induce differentiation, we cultured NSCs for 5 d in DMEM/F12/N2 medium supplemented with 2% fetal bovine serum (vol/vol, Life Technologies) and 1 µM retinoic acid (Biomol). Rat hippocampal astrocytes were isolated from Fisher 344 rats (Charles River) as previously described 22 and cultured on polyornithine/laminin-coated plates in DMEM/F12/N2 supplemented with 10% fetal bovine serum, with subculture on reaching 90% confluency using Trypsin EDTA (Mediatech).
Fc-ephrin-B2 synthesis and differentiation assays. To generate Fc-ephrin-B2, we incubated mouse ephrin-B2/Fc (Sigma Aldrich) at a 9:1 ratio (wt/wt) with a goat antibody to human IgG Fc (Jackson ImmunoResearch, cat. #109-005-098) for 90 min at 4 °C before immediate use. To differentiate NSC in vitro, we seeded eight-well chamber slides with 5 × 10 4 cells per well in standard culture medium containing 20 ng ml −1 FGF-2. The next day, the medium was replaced with DMEM/F12 containing 0.5 ng ml −1 FGF-2 and various concentrations of Fcephrin-B2. Differentiation experiments were performed over a 4-d period with a 50% media change daily. Then, the cells were fixed using 4% paraformaldehyde (PFA, Sigma Aldrich) and stained using standard protocols (see below). To test the effect of Eph receptor blocking, we pre-incubated NSCs with goat antibodies to EphB4 or EphB2 (1:50, Santa Cruz Biotechnology, cat. #sc-7285 and #sc-1763) for 30 min before addition of Fc-ephrin-B2 ligands. lentiviral and retroviral vector construction. DNA cassettes containing either human or mouse U6 promoter-driven expression of candidate shRNAs to rat Efnb2 (Gene ID: 306636) were constructed by PCR. The forward primer containing a PacI site for cloning and the reverse primer containing the entire shRNA sequence were used to amplify the U6 promoter from template plasmids pFhU6ABCgUGW (unpublished observation) or pmU6 pro. PCR was performed using Phusion high-fidelity polymerase (Finnzymes) under the following conditions: pre-incubation at 98 °C for 2 min, 30 cycles, with 1 cycle consisting of 12 s at 98 °C, 30 s at 55-65 °C, and 15-25 s at 72 °C, and a final extension step of 2 min at 72 °C. The U6 sense primers were sense_hU6 (5′-AACAATTAATTAAAA GGTCGGGCAGGAAGAGGGCCTATT-3′) and sense_mU6 (5′-AACAATT AATTAAATCCGACGCCGCCATCTCTAGGCC-3′). For a listing of the shRNA encoding antisense primers, see Supplementary table 1. In parallel, a control shRNA cassette against lacZ was constructed 50 analogously, using pBS U6 shRNA β-gal as the template and with primers listed in Supplementary table 1. All PCR products were digested with PacI and cloned into the pFUGW lentiviral vector 51 upstream of the human UBC promoter and eGFP. pCLGPIT-GSK3β S9A, encoding a constitutively active form of GSK3β (a gift of A. Fritz and S. Agrawal, University of California, Berkeley), was constructed by amplifying the GSK3β sequence from rat NSC cDNA, inserting it into pCLGPIT, and subjecting the plasmid to a site-directed mutagenesis to introduce the S9A mutation. Lentiviral and retroviral vectors were packaged using standard methods as described elsewhere 52, 53 . Lastly, to validate functionality of the Efnb2 shRNA vectors, the mouse Gfap promoter 54 , as well as the human GFAP promoter 55 , was cloned into the digested pFUGW vector, replacing the UBC promoter upstream of eGFP.
ephrin-B2 RnAi co-cultures. To select effective shRNA sequences targeting Efnb2, we transduced hippocampus-derived astrocytes with lentivirus encoding trial shRNA sequences at a multiplicity of infection (MOI) of 3 and cultured them for 4 d. RNA isolated from astrocyte cultures was analyzed for Efnb2 expression using QPCR (see below and Supplementary Fig. 3 ). For co-culture assays, hippocampus-derived astrocytes were transduced with lentivirus encoding shRNA sequences at an MOI of 3 and cultured for 2 d before a 3-d incubation in medium containing 20 µM cytosine arabinoside (AraC, Sigma Aldrich) to deplete rapidly dividing astrocytes. Cells were then returned to standard medium for 24 h before being subcultured onto eight-well chamber slides at a density of 70,000 cells per cm 2 . NSCs were transduced with retrovirus encoding either pCLGPIT or pCLGPIT-GSK3β S9A at an MOI of 1 and cultured for 2 d before a 96-h selection period in medium containing 1 µg ml −1 puromycin (Sigma Aldrich). Next, NSCs were incubated in standard media containing 25 µM BrdU (Sigma Aldrich) for 48 h. The BrdU-labeled NSCs were then seeded on top of a monolayer of astrocytes in eight-well chamber slides at a density of 70,000 cells per cm 2 in medium lacking FGF-2. Co-cultures were maintained for 6 d before fixation and analysis by immunocytochemistry.
